The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Quinuclidines

This is a "connection" page, showing publications Olatoyosi Odenike has written about Quinuclidines.
Connection Strength

0.048
  1. Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study. Lancet Haematol. 2023 Apr; 10(4):e272-e283.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.